Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulen vs Budesonide in Newly Diagnosed Crohn's Disease
NCT04233463Unknown
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in Crohn's disease, sponsored by Hillel Yaffe Medical Center. Primary endpoints: Clinical Response at 8 weeks, Mucosal Healing at 8 weeks and 1 more. Status: unknown.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04233463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233463.